drugset / Trial / NCT04951232
Clinical Study of Cinepazide Maleate Injection in the Treatment of Acute Ischemic Stroke
Completed
1000 enrolled
Peking University Third Hospital
Peking Union Medical College Hospital · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter, randomized, double-blind, placebo-controlled, parallel controlled, post marketing confirmatory clinical trial in Chinese patients with acute ischemic stroke. Objective to evaluate the efficacy and safety of cinepazide maleate injection compared with placebo in the treatment of patients with acute ischemic stroke.
Timeline
- Start
- 2016-07-04
- Primary completion
- 2017-01-06
- Completion
- 2017-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cinepazide | Small molecule | 320 mg | Intravenous |